Pharmaceutical companies and big pharma retailers stand to gain from the immense buying power of the National Health Insurance Fund once it is in operation – but contracting will to be negotiated, and doubt remain about the state’s capacity to pay on time.
The expected impacts of the NHI on pharmaceutical companies and retailers include concerns over pricing regulations, procurement models, potential reductions in earnings for suppliers, and the need for collaboration between the public and private sectors to ensure a sustainable healthcare system.
However, “lower pricing for pharmaceuticals suggests lower earnings for suppliers , particularly those that serve South Africa as a primary market,”
Portugal Últimas Notícias, Portugal Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Fonte: News24 - 🏆 4. / 80 Consulte Mais informação »